Your unique biology, goals, and lifestyle make you, you
Contact us today to schedule your consultation and discuss whether BPC-157 may fit your care plan from the inside out
BPC-157 ulcerative colitis: what the research says BPC-157 is a small peptide first described in gastric juice
[2] [16] Dietary deficiency without neurological features: Initial loading doses followed by maintenance therapy, with consideration of oral supplementation in appropriate cases
Product Details: Molecular Formula: CHNO Molecular Weight: 1419.54 g/mol TB500 (Thymosin Beta-4 Fragment) Molecular Formula: CHNOS Molecular Weight: 4963.49 g/mol Form: Lyophilized Powder Product Description: This product is a research-only peptide blend containing BPC-157 and TB-500 in lyophilized form, provided exclusively for laboratory use in qualified research settings
Nausea is the most frequently reported side effect, occurring in 20% to 47% of clinical trial participants depending on the dose